Skip to main content

Post MI: ACE inhibitor or ARB therapy

CBE ID
0594
1.5 Project
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description

This measure identifies patients with ST elevation MI (STEMI), or non-ST elevation MI (NSTEMI) plus a history of hypertension, heart failure and/or diabetes prior to the measurement year who are taking an ACEI or an ARB during the measurement year.

    Measure Specs
      General Information
      1.7 Measure Type
      1.3 Electronic Clinical Quality Measure (eCQM)
      1.20 Types of Data Sources
      1.14 Numerator

      Patients in the denominator with at least 1 Rx claim for an ACEI or an ARB medication during the measurement year

      Time Window: See below

      1.15 Denominator

      Patients with STEMI, or NSTEMI with hypertension, HF and/or diabetes, prior to the measurement year

      Tine Window: See below

      Exclusions

      Excludes members who meet the following criteria for the ACE/ARB contraindication
      - >=1 claim with a diagnosis code for ´hyperkalemia´, ´renal artery stenosis´, ´ESRD´, ´severe chronic kidney disease´, ´pregnancy´, or ´angioneurotic edema´ (see below for the complete list of ICD9 codes)´

      Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Cardiovascular Project 2014-2015
      Initial Endorsement
      Last Updated
      Removal Date
      Steward Organization
      Resolution Health, Inc.
      Steward POC email
      aurel.iuga@wellpoint.com
                Public Comments